RUNX3 and neoplasm: However, RUNX3 methylation levels were not found to be associated with stage (P = 0.307) and differentiation (P = 0.179) of tumours, but higher levels were linked with vascular (P = 0.006) and lymphatic (P = 0.002) invasions and worse prognosis (P = 0.038) [20].